![Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal - Medical Conferences Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal - Medical Conferences](https://conferences.medicom-publishers.com/wp-content/uploads/2022/05/Figure-Contrary-to-other-IL-4_IL-13-blockers.png)
Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal - Medical Conferences
![The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice | SpringerLink The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12265-021-10147-3/MediaObjects/12265_2021_10147_Sch1_HTML.png)
The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice | SpringerLink
![Separate issue severity and priority into two separate labelling schemes · Issue #18160 · eclipse/che · GitHub Separate issue severity and priority into two separate labelling schemes · Issue #18160 · eclipse/che · GitHub](https://user-images.githubusercontent.com/436777/98113981-c6942700-1ea4-11eb-8345-922f83a3d55a.png)